Your browser doesn't support javascript.
loading
Learnings From the Graveyard of Phase 2 and 3 Nonalcoholic Steatohepatitis Trials.
Francque, Sven M; Noureddin, Mazen; Krag, Aleksander.
Affiliation
  • Francque SM; Department of Gastroenterology Hepatology, Antwerp University Hospital, Edegem, Belgium; InflaMed Centre of Excellence, Laboratory for Experimental Medicine and Paediatrics, Translational Sciences in Inflammation and Immunology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.
  • Noureddin M; Houston Research Institute, Houston, Texas; Houston Methodist Hospital, Houston, Texas.
  • Krag A; Centre for Liver Research, Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.
Clin Gastroenterol Hepatol ; 22(1): 16-19, 2024 01.
Article in En | MEDLINE | ID: mdl-37517632
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Year: 2024 Type: Article